A clinical trial to see the effects of Pathyadi Kwatha and Anu Taila Nasya in Patients withArdhavabhedaka (Migraine)

Phase 2

• Conditions: Health Condition 1: G431- Migraine with auraHealth Condition 2: G430- Migraine without aura

• Registration Number: CTRI/2019/07/020392
• Lead Sponsor: Central Council For Research In Ayurvedic SciencesCCRAS

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients of either sex aged in between 18 to 60 years.

2.Diagnosed cases of Migraine with aura /without aura as per as per International Headache Society-ICHD-III (International classification of Headache Disorders 3rd version).

3.Patients with up to Grade III on MIDAS Scale.

4.Frequency of headache is > two times in a month.

5.Willing and able to participate for 3 months (consent to be obtained from patients).

Exclusion Criteria

1.Patients who were suffering with headache due to space occupying lesions and other secondary reasons.

2.Patients with severe infection and/or clinically significant respiratory, cardiac or haematological disorders.

3.Hypertensive patients who are on β blockers.

4.Patients with uncontrolled Diabetes mellitus (HbA1C >8%).

5.Patients with uncontrolled Hypothyroidism (S.TSH >10mIU/ml).

6.Patients with concurrent serious Hepatic Dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.4 mg/dl)

7.Alcoholics and/or drug abusers.

8.Known cases of malignancy.

9.Pregnant women or planning to conceive or lactating woman.

10.Patients in whom another investigational drug was used within 3 months prior to entry in this study.

11.Any other condition, which the PI thinks, may jeopardize the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified